MENU
+Compare
BMKDF
Stock ticker: OTC
AS OF
Aug 6 closing price
Price
$0.25
Change
-$0.00 (-0.00%)
Capitalization
14.45M

BMKDF Biomark Diagnostics Inc. Forecast, Technical & Fundamental Analysis

Biomark Diagnostics Inc is a Canada-based oncology-focused company... Show more

BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMKDF with price predictions
Aug 06, 2025

BMKDF in +4.54% Uptrend, advancing for three consecutive days on August 06, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BMKDF advanced for three days, in of 48 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where BMKDF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 31, 2025. You may want to consider a long position or call options on BMKDF as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

BMKDF moved above its 50-day moving average on July 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for BMKDF moved out of overbought territory on July 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for BMKDF turned negative on July 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

BMKDF broke above its upper Bollinger Band on July 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMKDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.599). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (111.111) is also within normal values, averaging (43.219).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMKDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
130 - 3851 Shell Road
Phone
+1 604 836-6950
Employees
4
Web
https://www.biomarkdiagnostics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGCO0.15N/A
N/A
Financial Gravity Companies, Inc.
XNYIF0.35N/A
N/A
Xinyi Solar Holdings Limited
KPLIF0.27N/A
N/A
Keppel Infrastructure Trust
PONT552.00N/A
N/A
Pontiac Bancorp, Inc.
AUSTF0.24N/A
-1.00%
Austin Engineering Ltd.

BMKDF and Stocks

Correlation & Price change

A.I.dvisor tells us that BMKDF and PAVM have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMKDF and PAVM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMKDF
1D Price
Change %
BMKDF100%
+1.20%
PAVM - BMKDF
22%
Poorly correlated
-5.27%
IOBCF - BMKDF
20%
Poorly correlated
N/A
LUNG - BMKDF
10%
Poorly correlated
-1.83%
ELUT - BMKDF
6%
Poorly correlated
-3.43%
BFLY - BMKDF
3%
Poorly correlated
-3.50%
More